Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 5Sarcoma 2Other hematologic neoplasm 1

Conditions

Sarcoma 266Osteosarcoma 81Sarcoma, Ewing 51Melanoma 44Neoplasms 43Gastrointestinal Stromal Tumors 41Colorectal Neoplasms 39Breast Neoplasms 38Rhabdomyosarcoma 36Bone Neoplasms 36Ovarian Neoplasms 32Neoplasm Metastasis 32Neuroblastoma 30Pancreatic Neoplasms 29Stomach Neoplasms 27Dendritic Cell Sarcoma, Interdigitating 27Lung Neoplasms 26Liposarcoma 26Leiomyosarcoma 26Glioblastoma 23Uterine Cervical Neoplasms 22Sarcoma, Synovial 22Head and Neck Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Esophageal Neoplasms 21Lymphoma 19Sarcoma, Kaposi 18Prostatic Neoplasms 18Carcinoma, Hepatocellular 18Urinary Bladder Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Primary Effusion × Sarcoma × Clear all
NCT00006518 2026-06-05

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

National Institutes of Health Clinical Center (CC)

Recruiting
1,029 enrolled
LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Lymphoma, Neoplasms, Sarcoma, Kaposi, Virus Diseases, Lymphoma, Primary Effusion

NCT05907759 2026-06-02

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
28 enrolled
LymphoidSarcoma

Multi-centric Castleman's Disease, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡